Skip to main content
. 2013 Nov 30;35(4):784–794. doi: 10.1093/carcin/bgt390

Fig. 5.

Fig. 5.

WNT5A stimulates aerobic glycolysis via the activation of Akt signalling. (A) A2058 cells treated with rWNT5A for 30–90min have increased phospho-Akt (p-Akt) levels compared with carrier-treated cells, as determined by immunoblotting. Example experiment of 5 is shown. (B) Inhibition of rWNT5A-mediated increase in lactate secretion in A2058 cells by MK-2206 (an allosteric Akt-1, -2 and -3 inhibitor) treatment. N = 3. (C) Inhibition of rWNT5A-mediated increase in lactate secretion in A2058 cells by rapamycin (mTOR complex-1 inhibitor) treatment. N = 3.